CHEK2 and breast carcinoma: The tool allows an individualised estimation of lifetime breast cancer risk in the carriers and non-carriers of variants in BRCA1, BRCA2, PALB2, CHEK2, ATM, RAD51C, RAD51D, and BRIP1, and considers these modifiers of disease which may inform risk management.